tirzepatide off patent Challenged Again! FDA confirms tirzepatide shortage is
Description
Tirzepatide is a once-weekly injectable medication initially developed to treat type 2 diabetes
By the time you reach higher doses, you exceed the capacity of a standard 1mL insulin syringe
Your Mochi provider will assess whether escalation beyond 10mg is appropriate based on your weight loss trajectory, side effect profile, and remaining weight loss goals
How often should you rotate tirzepatide injection sites
Heres What to Do Missed a weekly dose
Get continuous care from your doctor STEP 3 Message your care team anytime for dose adjustments, check-ins, and ongoing support that keeps you progressing toward your goals
